Provectus Biopharmaceuticals, Inc. (PVCT)

USD 0.1

(-3.01%)

Long Term Debt Summary of Provectus Biopharmaceuticals, Inc.

  • Provectus Biopharmaceuticals, Inc.'s latest annual long term debt in 2023 was 25.29 Thousand USD , down -65.52% from previous year.
  • Provectus Biopharmaceuticals, Inc.'s latest quarterly long term debt in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Provectus Biopharmaceuticals, Inc. reported annual long term debt of 73.37 Thousand USD in 2022, down 0.0% from previous year.
  • Provectus Biopharmaceuticals, Inc. reported annual long term debt of - USD in 2021, down -100.0% from previous year.
  • Provectus Biopharmaceuticals, Inc. reported quarterly long term debt of 12.72 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • Provectus Biopharmaceuticals, Inc. reported quarterly long term debt of 25.29 Thousand USD for 2023 FY, down -65.52% from previous quarter.

Annual Long Term Debt Chart of Provectus Biopharmaceuticals, Inc. (2023 - 1999)

Historical Annual Long Term Debt of Provectus Biopharmaceuticals, Inc. (2023 - 1999)

Year Long Term Debt Long Term Debt Growth
2023 25.29 Thousand USD -65.52%
2022 73.37 Thousand USD 0.0%
2021 - USD -100.0%
2020 83.84 Thousand USD -99.58%
2019 19.79 Million USD 42.1%
2018 13.93 Million USD 47.34%
2017 9.45 Million USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD -100.0%
2005 322.71 Thousand USD -44.64%
2004 582.94 Thousand USD 291.24%
2003 149 Thousand USD -84.93%
2002 988.65 Thousand USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%

Peer Long Term Debt Comparison of Provectus Biopharmaceuticals, Inc.

Name Long Term Debt Long Term Debt Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -216.238%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 98.559%
Qrons Inc. 80 Thousand USD 68.376%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 99.875%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. 171.23 Thousand USD 85.225%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 99.879%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD 56.859%
Mesoblast Limited 100.29 Million USD 99.975%
Marizyme, Inc. 667.12 Thousand USD 96.208%
Genus plc 228.2 Million USD 99.989%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.985%
Therapeutic Solutions International, Inc. 5512.00 USD -358.98%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 98.855%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 98.197%
IMV Inc. 27.39 Million USD 99.908%
AXIM Biotechnologies, Inc. 5.42 Million USD 99.534%
MultiCell Technologies, Inc. 36.43 USD -69345.512%
ONE Bio Corp. 592.19 Thousand USD 95.728%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.955%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 98.863%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 97.94%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 95.438%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 98.667%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 92.143%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 100.0%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD 83.134%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD 84.593%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 99.835%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -467.751%
Genscript Biotech Corporation 287.12 Million USD 99.991%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD 79.969%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 88.966%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 88.986%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 99.694%
BioStem Technologies, Inc. 265.63 Thousand USD 90.476%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -2277.726%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 83.09%
Regen BioPharma, Inc. 149.61 Thousand USD 83.09%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD 82.057%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 99.676%
SYBLEU INC 300 Thousand USD 91.567%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 93.145%
International Stem Cell Corporation 445 Thousand USD 94.315%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 99.69%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 94.464%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 97.821%
PureTech Health plc 18.25 Million USD 99.861%
Coeptis Therapeutics, Inc. 150 Thousand USD 83.134%
IXICO plc 275 Thousand USD 90.8%
IntelGenx Technologies Corp. 11.83 Million USD 99.786%
Gelesis Holdings, Inc. 26.3 Million USD 99.904%
CSL Limited 11.23 Billion USD 100.0%
Cellectis S.A. 36.21 Million USD 99.93%